TTM
$3.55B
YoY change
+55.7%
5Y CAGR
—
Peak year (2019)
$4.70B
Cumulative net income
$7.37B
Net Income history chart for Boston Scientific (BSX) from 1991 to 2025
Latest: $2.89B
Net Income growth chart for Boston Scientific (BSX) from 1991 to 2025
Latest: +55.7%
Net Income history table for Boston Scientific (BSX) from 1991 to 2025
| 2025 | $2.89B | +55.7% | +$1.03B | ||
| 2024 | $1.85B | +16.4% | +$261.00M | ||
| 2023 | $1.59B | +128.2% | +$895.00M | ||
| 2022 | $698.00M | -32.9% | −$342.00M | ||
| 2021 | $1.04B | -1368.3% | +$1.12B | ||
| 2020 | −$82.00M | -101.7% | −$4.78B | ||
| 2019 | $4.70B | +181.3% | +$3.03B | ||
| 2018 | $1.67B | +1506.7% | +$1.57B | ||
| 2017 | $104.00M | -70.0% | −$243.00M | ||
| 2016 | $347.00M | -245.2% | +$586.00M | ||
| 2015 | −$239.00M | +100.8% | −$120.00M | ||
| 2014 | −$119.00M | -1.7% | +$2.00M | ||
| 2013 | −$121.00M | -97.0% | +$3.95B | ||
| 2012 | −$4.07B | -1022.4% | −$4.51B | ||
| 2011 | $441.00M | -141.4% | +$1.51B | ||
| 2010 | −$1.06B | +3.9% | −$40.00M | ||
| 2009 | −$1.02B | -49.7% | +$1.01B | ||
| 2008 | −$2.04B | +311.3% | −$1.54B | ||
| 2007 | −$495.00M | -86.2% | +$3.08B | ||
| 2006 | −$3.58B | -669.6% | −$4.21B | ||
| 2005 | $628.00M | -40.9% | −$434.00M | ||
| 2004 | $1.06B | +125.0% | +$590.00M | ||
| 2003 | $472.00M | +26.5% | +$99.00M | ||
| 2002 | $373.00M | -790.7% | +$427.00M | ||
| 2001 | −$54.00M | -114.5% | −$427.00M | ||
| 2000 | $373.00M | +0.5% | +$2.00M | ||
| 1999 | $371.00M | -240.3% | +$635.40M | ||
| 1998 | −$264.40M | -289.8% | −$403.70M | ||
| 1997 | $139.30M | -16.6% | −$27.80M | ||
| 1996 | $167.10M | +1988.8% | +$159.10M | ||
| 1995 | $8.00M | -90.0% | −$71.70M | ||
| 1994 | $79.70M | +14.3% | +$10.00M | ||
| 1993 | $69.70M | +23.1% | +$13.10M | ||
| 1992 | $56.60M | +35.4% | +$14.80M | ||
| 1991 | $41.80M | — | — |
- 2025$2.89B+55.7%
- 2024$1.85B+16.4%
- 2023$1.59B+128.2%
- 2022$698.00M-32.9%
- 2021$1.04B-1368.3%
- 2020−$82.00M-101.7%
- 2019$4.70B+181.3%
- 2018$1.67B+1506.7%
- 2017$104.00M-70.0%
- 2016$347.00M-245.2%
- 2015−$239.00M+100.8%
- 2014−$119.00M-1.7%
- 2013−$121.00M-97.0%
- 2012−$4.07B-1022.4%
- 2011$441.00M-141.4%
- 2010−$1.06B+3.9%
- 2009−$1.02B-49.7%
- 2008−$2.04B+311.3%
- 2007−$495.00M-86.2%
- 2006−$3.58B-669.6%
- 2005$628.00M-40.9%
- 2004$1.06B+125.0%
- 2003$472.00M+26.5%
- 2002$373.00M-790.7%
- 2001−$54.00M-114.5%
- 2000$373.00M+0.5%
- 1999$371.00M-240.3%
- 1998−$264.40M-289.8%
- 1997$139.30M-16.6%
- 1996$167.10M+1988.8%
- 1995$8.00M-90.0%
- 1994$79.70M+14.3%
- 1993$69.70M+23.1%
- 1992$56.60M+35.4%
- 1991$41.80M—
Net Income values are taken from Boston Scientific's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current net income (TTM) is $3.55B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Boston Scientific (BSX) net income is $2.89B – surged 55.7% year-over-year.
Boston Scientific net income plunged from $4.70B in 2019 to $2.89B in 2025, a 38.6% drawdown.
$4.70B stands as the all-time-high annual net income, posted in 2019, against a low of −$4.07B during 2012.
Boston Scientific Net Income by Year
Boston Scientific Net Income 2025: $2.89B
Boston Scientific posted net income of $2.89B in 2025, surged 55.7% from 2024.
Boston Scientific Net Income 2024: $1.85B
In 2024, Boston Scientific reported net income of $1.85B, grew 16.4% from 2023.
Boston Scientific Net Income 2023: $1.59B
Boston Scientific net income in 2023 was $1.59B, surged 128.2% from 2022.
Boston Scientific Net Income 2022: $698.00M
2022's net income for Boston Scientific came in at $698.00M, plunged 32.9% below 2021.
Boston Scientific Net Income 2021: $1.04B
Boston Scientific net income in 2021 was $1.04B.
See more financial history for Boston Scientific (BSX).
Sector peers by Net Income
Healthcare peers of Boston Scientific (BSX), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation